市場調査レポート
商品コード
1575021

PoC感染症検査市場:疾患タイプ別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年~2032年の予測

PoC Infectious Disease Testing Market, By Disease Type, By Technology, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032


出版日
ページ情報
英文 322 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.96円
PoC感染症検査市場:疾患タイプ別、技術別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2024年~2032年の予測
出版日: 2024年10月02日
発行: AnalystView Market Insights
ページ情報: 英文 322 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

PoC感染症検査市場規模は2023年に114億9,832万米ドルとなり、2024年から2032年にかけてCAGR 4.40%で拡大

PoC感染症検査市場-市場力学

感染症の流行と迅速診断の必要性の増加、デジタル化が市場の需要を促進する見込み

COVID-19、インフルエンザ、HIV、結核、性感染症などの感染症罹患率の増加により、迅速で信頼性の高い診断に対する需要が高まっています。PCRのような分子診断、イムノアッセイ、マイクロ流体などの検査技術の革新により、POCT装置の感度、特異性、使いやすさが向上し、POC検査の需要が高まっています。また、早期診断や定期的なスクリーニングの利点に関する一般市民の意識も高まっており、市場の成長に寄与しています。

さらに、POCTは専門的な検査施設や人員を必要としないため、検査コスト全体を削減します。POCT機器をデジタルヘルスプラットフォームや電子カルテ(EMR)と統合することで、シームレスなデータ共有、遠隔モニタリング、疾病管理の改善が可能になります。新興国は、ヘルスケアインフラや熟練した人材の不足に対処するため、POCTソリューションを採用しています。コネクティビティ機能により、疾病発生の追跡や疫学サーベイランスの向上が可能になります。これらのメリットは市場の成長を後押しすると期待されています。

POC感染症検査市場-主要洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間(2024-2032年)に約4.40%のCAGRで毎年成長すると推定されます。

疾患タイプ別では、2023年には、迅速診断へのニーズの高さから、COVID-19疾患が最大の市場シェアを占めると予測されています。

技術別では、分子検査の発展により、2023年には分子診断薬セグメントが主要技術セグメントとなった。

エンドユーザー別では、POC診断ラボやセンターなどの増加により、2023年のエンドユーザーは診療所がトップでした。

地域別では、高度なヘルスケア技術とインフラが存在するため、北米が2023年の主要収益源でした。

PoC感染症検査市場-セグメンテーション分析:

世界のPoC感染症検査市場は、疾患タイプ、技術、エンドユーザー、地域に基づいてセグメント化されます。

市場は疾患タイプに基づいて7つのカテゴリーに分類される:HIV、インフルエンザ、結核・薬剤耐性POC、HBV POC、HPV POC、COVID-19疾患、その他。COVID-19疾患セグメントが市場を独占しています。COVID-19のPCR検査による需要の増加がセグメントの成長を後押ししています。

市場は技術によって4つのカテゴリーに分類される:ラテラルフロー免疫測定法、凝集試験、分子診断法、その他。市場を独占しているのは分子診断分野です。分子検査は精度が高く、遺伝子材料処理に適しているため、同分野の需要が加速しています。

市場はエンドユーザー別に病院、診療所、在宅医療、その他の4つに分類されます。診療所市場が市場を独占しており、予測期間中も高い優位性を維持すると予想されます。POC感染症の迅速な治療を提供する臨床センターの増加が市場成長を後押ししています。

POC感染症検査市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米、特に米国は、先進的なヘルスケアインフラ、高い疾病負担、迅速診断への強い関心から、世界のPOCT市場で最大のシェアを占めています。アジア太平洋地域は、人口の多さ、感染症流行の増加、早期診断に対する意識の高まりから、最も高い成長率が見込まれています。POCTの導入は、集中的な検査施設へのアクセス不足に対処するため、特に農村部や遠隔地で進んでいます。

POC感染症検査市場-競合情勢:

PoC感染症検査市場は競争が激しく、多数の世界企業や地域企業が存在することが特徴です。各社は、クラウドベースのデータ管理や遠隔モニタリングなどのデジタルヘルスソリューションをPOCT製品に統合するための投資を増やしています。さらに、各社はCRISPRベースの診断薬や自動デジタルリーダーなどの次世代技術を通じて、POCTデバイスの感度と特異度の向上に注力しています。

2024年1月、ロシュはルミラデックスのPOCT技術の買収を完了しました。ルミラデックスのプラットフォームには一連の免疫測定と臨床化学検査が含まれます。

2023年2月、サーモフィッシャーサイエンティフィックがマイラボと提携し、インドで感染症用RTPCRキットを発売。

目次

第1章 PoC感染症検査市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 PoC感染症検査の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 PoC感染症検査業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 PoC感染症検査市場: COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 PoC感染症検査市場情勢

  • PoC感染症検査市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 PoC感染症検査市場- 疾患タイプ別

  • 概要
    • 疾病タイプ別セグメントシェア分析
    • HIV
    • インフルエンザ
    • 結核と薬剤耐性POC
    • HBV POC
    • HPV POC
    • COVID-19
    • その他

第8章 PoC感染症検査市場- 技術別

  • 概要
    • 技術別セグメントシェア分析
    • ラテラルフロー免疫測定法
    • 凝集試験
    • 分子診断
    • その他

第9章 PoC感染症検査市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 診療所
    • 在宅ケア
    • その他

第10章 PoC感染症検査市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析-PoC感染症検査業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Abbott Laboratories
    • Roche Diagnostics
    • QuidelOrtho Corporation
    • Siemens Healthineers
    • Becton, Dickinson and Company
    • Cepheid
    • bioMerieux
    • Thermo Fisher Scientific
    • Hologic, Inc.
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific
    • Chembio Diagnostics, Inc.
    • PerkinElmer, Inc.
    • Sekisui Diagnostics
    • Trinity Biotech plc
    • Others

第12章 アナリストの全方位展望

目次
Product Code: ANV3976

REPORT HIGHLIGHT

PoC Infectious Disease Testing Market size was valued at USD 11,498.32 Million in 2023, expanding at a CAGR of 4.40% from 2024 to 2032.

Point of Care Infectious Disease Testing (POCT) refers to diagnostic tests conducted at or near the site of patient care, such as in a clinic, doctor's office, or at home. These tests are designed to detect infectious diseases quickly, providing results within minutes to a few hours. This enables healthcare providers to make immediate decisions about treatment and management, reducing the need for additional lab testing and follow-up visits.

PoC Infectious Disease Testing Market- Market Dynamics

Increasing prevalence of infectious diseases and need for rapid diagnostics along with digitization is expected to propel market demand

The increasing incidence of infectious diseases like COVID-19, influenza, HIV, tuberculosis, and sexually transmitted infections has heightened the demand for rapid and reliable diagnostics. Innovations in testing technologies, including molecular diagnostics like PCR, immunoassays, and microfluidics, have improved the sensitivity, specificity, and ease of use of POCT devices, boosting demand for POC testing. Public awareness regarding the benefits of early diagnosis and regular screening is also rising, contributing to market growth.

Further, POCT reduces the overall cost of testing by eliminating the need for specialized lab facilities and personnel. Integration of POCT devices with digital health platforms and electronic medical records (EMRs) allows for seamless data sharing, remote monitoring, and improved disease management. Emerging economies are adopting POCT solutions to address the shortage of healthcare infrastructure and skilled personnel. Connectivity features enable better tracking of disease outbreaks and epidemiological surveillance. These benefits are expected to bolster market growth.

PoC Infectious Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.40% over the forecast period (2024-2032)

Based on Disease Type segmentation, the COVID-19 disease segment was predicted to show maximum market share in the year 2023, owing to high need for fast diagnostics.

Based on Technology segmentation, molecular diagnostics segment was the leading Technology segment in 2023, due to the developments in molecular testing.

Based on End User segmentation, clinics segment was the leading End User segment in 2023, due to increasing number of POC diagnostics labs, centers, etc.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of advanced healthcare technology and infrastructure.

PoC Infectious Disease Testing Market- Segmentation Analysis:

Global PoC Infectious Disease Testing Market is segmented on the basis of Disease Type, Technology, End User, and Region.

The market is divided into seven categories based on Disease Type: HIV, influenza, TB & drug resistant POC, HBV POC, HPV POC, COVID-19 disease, and others. The COVID-19 disease segment dominates the market. The increasing demand from PCR testing for COVID-19 has boosted segment growth.

The market is divided into four categories based on Technology: lateral flow immunoassay, agglutination test, molecular diagnostics, and others. The molecular diagnostics segment dominates the market. The molecular tests are accurate and preferred in genetic material processing which is accelerating segment demand.

The market is divided into four categories based on End User: hospitals, clinics, homecare, and others. The clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. The rising number of clinical centers providing rapid treatment in POC infectious diseases is boosting market growth.

PoC Infectious Disease Testing Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America, particularly the United States, holds the largest share of the global POCT market due to its advanced healthcare infrastructure, high disease burden, and strong emphasis on rapid diagnostics. The Asia-Pacific region is expected to witness the highest growth rate due to the large population base, rising prevalence of infectious diseases, and growing awareness about early diagnosis. The adoption of POCT is particularly high in rural and remote areas to address the lack of access to centralized laboratory facilities.

PoC Infectious Disease Testing Market- Competitive Landscape:

The PoC Infectious Disease Testing market is highly competitive and characterized by the presence of numerous global and regional players. Companies are increasingly investing in integrating digital health solutions, such as cloud-based data management and remote monitoring, into their POCT products. In addition, companies are focusing on enhancing the sensitivity and specificity of their POCT devices through next-generation technologies, such as CRISPR-based diagnostics, and automated digital readers.

In January 2024, Roche completed acquisition of LumiraDx's point of care technology. The LumiraDx's platform includes a series of immunoassay and clinical chemical tests.

In February 2023, Thermo Fisher Scientific partnered with Mylab to introduce RTPCR kits for infectious disease in India.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET KEY PLAYERS

  • Abbott Laboratories
  • Roche Diagnostics
  • QuidelOrtho Corporation
  • Siemens Healthineers
  • Becton, Dickinson and Company
  • Cepheid
  • bioMerieux
  • Thermo Fisher Scientific
  • Hologic, Inc.
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific
  • Chembio Diagnostics, Inc.
  • PerkinElmer, Inc.
  • Sekisui Diagnostics
  • Trinity Biotech plc
  • Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • HIV
  • Influenza
  • TB & drug resistant POC
  • HBV POC
  • HPV POC
  • COVID-19 disease
  • Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019-2032

  • Lateral flow immunoassay
  • Agglutination test
  • Molecular diagnostics
  • Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital
  • Clinics
  • Homecare
  • Others

GLOBAL POC INFECTIOUS DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PoC Infectious Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PoC Infectious Disease Testing Market Snippet by Disease Type
    • 2.1.2. PoC Infectious Disease Testing Market Snippet by Technology
    • 2.1.3. PoC Infectious Disease Testing Market Snippet by End User
    • 2.1.4. PoC Infectious Disease Testing Market Snippet by Country
    • 2.1.5. PoC Infectious Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. PoC Infectious Disease Testing Key Market Trends

  • 3.1. PoC Infectious Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PoC Infectious Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PoC Infectious Disease Testing Market Opportunities
  • 3.4. PoC Infectious Disease Testing Market Future Trends

4. PoC Infectious Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PoC Infectious Disease Testing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PoC Infectious Disease Testing Market Landscape

  • 6.1. PoC Infectious Disease Testing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PoC Infectious Disease Testing Market - By Disease Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 7.1.2. HIV
    • 7.1.3. Influenza
    • 7.1.4. TB & drug resistant POC
    • 7.1.5. HBV POC
    • 7.1.6. HPV POC
    • 7.1.7. COVID-19 disease
    • 7.1.8. Others

8. PoC Infectious Disease Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
    • 8.1.2. Lateral flow immunoassay
    • 8.1.3. Agglutination test
    • 8.1.4. Molecular diagnostics
    • 8.1.5. Others

9. PoC Infectious Disease Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Clinics
    • 9.1.4. Homecare
    • 9.1.5. Others

10. PoC Infectious Disease Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. PoC Infectious Disease Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. PoC Infectious Disease Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. PoC Infectious Disease Testing Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. PoC Infectious Disease Testing Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. PoC Infectious Disease Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- PoC Infectious Disease Testing Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Abbott Laboratories
    • 11.2.2. Roche Diagnostics
    • 11.2.3. QuidelOrtho Corporation
    • 11.2.4. Siemens Healthineers
    • 11.2.5. Becton, Dickinson and Company
    • 11.2.6. Cepheid
    • 11.2.7. bioMerieux
    • 11.2.8. Thermo Fisher Scientific
    • 11.2.9. Hologic, Inc.
    • 11.2.10. Bio-Rad Laboratories, Inc.
    • 11.2.11. Thermo Fisher Scientific
    • 11.2.12. Chembio Diagnostics, Inc.
    • 11.2.13. PerkinElmer, Inc.
    • 11.2.14. Sekisui Diagnostics
    • 11.2.15. Trinity Biotech plc
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us